Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vulvar Neoplasms | 1 | 2020 | 18 | 0.710 |
Why?
|
| Myxoma | 1 | 2020 | 28 | 0.710 |
Why?
|
| Intrauterine Devices | 1 | 2019 | 14 | 0.670 |
Why?
|
| Contraceptive Agents, Female | 1 | 2019 | 29 | 0.650 |
Why?
|
| Adnexal Diseases | 1 | 2019 | 23 | 0.650 |
Why?
|
| Contraception | 1 | 2019 | 59 | 0.640 |
Why?
|
| Rare Diseases | 1 | 2020 | 185 | 0.610 |
Why?
|
| Vaginitis | 1 | 2018 | 6 | 0.610 |
Why?
|
| Hyperhidrosis | 1 | 2018 | 9 | 0.600 |
Why?
|
| Abscess | 1 | 2019 | 138 | 0.590 |
Why?
|
| Lichen Sclerosus et Atrophicus | 1 | 2014 | 3 | 0.460 |
Why?
|
| Comorbidity | 1 | 2019 | 1497 | 0.460 |
Why?
|
| Menorrhagia | 4 | 2020 | 74 | 0.410 |
Why?
|
| Groin | 1 | 2011 | 15 | 0.390 |
Why?
|
| Hair Removal | 1 | 2011 | 7 | 0.390 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 1 | 2011 | 9 | 0.390 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 280 | 0.390 |
Why?
|
| Puberty, Precocious | 1 | 2011 | 27 | 0.380 |
Why?
|
| Aromatase Inhibitors | 1 | 2011 | 75 | 0.370 |
Why?
|
| Nitriles | 1 | 2011 | 146 | 0.370 |
Why?
|
| Triazoles | 1 | 2011 | 138 | 0.360 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 643 | 0.340 |
Why?
|
| Adolescent | 17 | 2023 | 19095 | 0.310 |
Why?
|
| Kidney Diseases | 2 | 2023 | 478 | 0.280 |
Why?
|
| Ovarian Neoplasms | 2 | 2022 | 407 | 0.250 |
Why?
|
| Vaginal Diseases | 1 | 2023 | 17 | 0.220 |
Why?
|
| Female | 19 | 2023 | 65444 | 0.210 |
Why?
|
| Vagina | 3 | 2023 | 202 | 0.200 |
Why?
|
| Dysmenorrhea | 2 | 2019 | 14 | 0.200 |
Why?
|
| Sertoli-Leydig Cell Tumor | 1 | 2022 | 16 | 0.200 |
Why?
|
| Ribonuclease III | 1 | 2022 | 87 | 0.190 |
Why?
|
| Ultrasonography | 2 | 2019 | 941 | 0.180 |
Why?
|
| Intrauterine Device Expulsion | 1 | 2020 | 3 | 0.180 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2022 | 118 | 0.180 |
Why?
|
| Hirschsprung Disease | 1 | 2020 | 36 | 0.170 |
Why?
|
| Child | 12 | 2023 | 24225 | 0.170 |
Why?
|
| Menstruation | 1 | 2019 | 28 | 0.170 |
Why?
|
| Humans | 22 | 2023 | 123170 | 0.170 |
Why?
|
| Constipation | 1 | 2020 | 113 | 0.160 |
Why?
|
| Pelvic Pain | 2 | 2016 | 27 | 0.160 |
Why?
|
| Pregnancy in Adolescence | 1 | 2019 | 49 | 0.160 |
Why?
|
| Endometriosis | 2 | 2019 | 185 | 0.160 |
Why?
|
| Disorders of Sex Development | 1 | 2019 | 78 | 0.160 |
Why?
|
| Vomiting | 1 | 2019 | 115 | 0.150 |
Why?
|
| Aluminum Compounds | 1 | 2018 | 17 | 0.150 |
Why?
|
| Vulva | 1 | 2018 | 18 | 0.150 |
Why?
|
| Chlorides | 1 | 2018 | 104 | 0.150 |
Why?
|
| Abnormalities, Multiple | 1 | 2023 | 965 | 0.150 |
Why?
|
| Parovarian Cyst | 1 | 2017 | 11 | 0.140 |
Why?
|
| Hyperandrogenism | 1 | 2017 | 19 | 0.140 |
Why?
|
| Young Adult | 5 | 2020 | 8865 | 0.140 |
Why?
|
| Peritonitis | 1 | 2017 | 76 | 0.140 |
Why?
|
| Fever | 1 | 2019 | 296 | 0.140 |
Why?
|
| Abdominal Pain | 1 | 2019 | 307 | 0.140 |
Why?
|
| Dermoid Cyst | 1 | 2017 | 34 | 0.140 |
Why?
|
| Biopsy | 1 | 2020 | 1239 | 0.130 |
Why?
|
| Kidney | 2 | 2023 | 1338 | 0.130 |
Why?
|
| Congenital Abnormalities | 1 | 2019 | 246 | 0.130 |
Why?
|
| Menstruation Disturbances | 1 | 2016 | 13 | 0.130 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2016 | 17 | 0.130 |
Why?
|
| Sex Reassignment Procedures | 1 | 2016 | 18 | 0.130 |
Why?
|
| Turner Syndrome | 1 | 2016 | 47 | 0.130 |
Why?
|
| Wnt Proteins | 1 | 2017 | 198 | 0.130 |
Why?
|
| Puberty | 1 | 2016 | 94 | 0.130 |
Why?
|
| Laparotomy | 1 | 2017 | 135 | 0.130 |
Why?
|
| Genital Diseases, Female | 1 | 2016 | 32 | 0.130 |
Why?
|
| Fistula | 1 | 2016 | 50 | 0.130 |
Why?
|
| Teratoma | 1 | 2017 | 123 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 134 | 0.130 |
Why?
|
| Blood Coagulation Disorders | 1 | 2016 | 100 | 0.120 |
Why?
|
| Mobile Applications | 1 | 2016 | 91 | 0.120 |
Why?
|
| Retrospective Studies | 8 | 2023 | 15998 | 0.120 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2014 | 88 | 0.120 |
Why?
|
| Self Care | 1 | 2016 | 212 | 0.120 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 110 | 0.120 |
Why?
|
| Adenomyosis | 1 | 2014 | 10 | 0.120 |
Why?
|
| Leuprolide | 1 | 2014 | 25 | 0.120 |
Why?
|
| Contraceptives, Oral | 1 | 2014 | 38 | 0.120 |
Why?
|
| Betamethasone Valerate | 1 | 2014 | 1 | 0.120 |
Why?
|
| Clobetasol | 1 | 2014 | 3 | 0.120 |
Why?
|
| Fertility | 1 | 2016 | 263 | 0.110 |
Why?
|
| Tacrolimus | 1 | 2014 | 99 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 441 | 0.110 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 253 | 0.110 |
Why?
|
| Incidence | 3 | 2020 | 3049 | 0.100 |
Why?
|
| Crohn Disease | 1 | 2016 | 283 | 0.100 |
Why?
|
| Texas | 4 | 2017 | 3547 | 0.100 |
Why?
|
| Safe Sex | 1 | 2012 | 16 | 0.100 |
Why?
|
| Body Piercing | 1 | 2011 | 4 | 0.100 |
Why?
|
| Lip | 1 | 2011 | 15 | 0.100 |
Why?
|
| Mullerian Ducts | 1 | 2012 | 40 | 0.100 |
Why?
|
| Genitalia, Female | 1 | 2012 | 48 | 0.100 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2012 | 93 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2017 | 501 | 0.090 |
Why?
|
| Risk Reduction Behavior | 1 | 2012 | 134 | 0.090 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2012 | 70 | 0.090 |
Why?
|
| Abdomen | 1 | 2011 | 130 | 0.090 |
Why?
|
| Blood Platelet Disorders | 1 | 2010 | 13 | 0.090 |
Why?
|
| Health Education | 1 | 2012 | 225 | 0.090 |
Why?
|
| Recurrence | 1 | 2014 | 1422 | 0.090 |
Why?
|
| Sexual Behavior | 1 | 2011 | 235 | 0.080 |
Why?
|
| Urogenital Abnormalities | 1 | 2012 | 168 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3526 | 0.080 |
Why?
|
| Pregnancy | 2 | 2019 | 7137 | 0.080 |
Why?
|
| Blood Platelets | 1 | 2010 | 333 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 2397 | 0.070 |
Why?
|
| Brain | 1 | 2019 | 2947 | 0.070 |
Why?
|
| Hormones | 2 | 2019 | 190 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 826 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 1873 | 0.070 |
Why?
|
| Adult | 4 | 2019 | 29034 | 0.060 |
Why?
|
| Obesity | 1 | 2017 | 2227 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3011 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2012 | 3660 | 0.060 |
Why?
|
| Uterus | 2 | 2023 | 594 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2017 | 13880 | 0.050 |
Why?
|
| Cloaca | 1 | 2020 | 16 | 0.040 |
Why?
|
| Pelvic Floor | 1 | 2020 | 34 | 0.040 |
Why?
|
| Hospitals, Pediatric | 2 | 2017 | 780 | 0.040 |
Why?
|
| Sexual Development | 1 | 2019 | 23 | 0.040 |
Why?
|
| Program Development | 1 | 2020 | 190 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 4704 | 0.040 |
Why?
|
| Hirsutism | 1 | 2017 | 19 | 0.040 |
Why?
|
| Menarche | 1 | 2017 | 33 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2023 | 8103 | 0.040 |
Why?
|
| Ovarian Cysts | 1 | 2017 | 24 | 0.040 |
Why?
|
| MP3-Player | 1 | 2016 | 6 | 0.030 |
Why?
|
| Metrorrhagia | 1 | 2016 | 7 | 0.030 |
Why?
|
| Anemia | 1 | 2020 | 339 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2017 | 181 | 0.030 |
Why?
|
| Antifibrinolytic Agents | 1 | 2016 | 33 | 0.030 |
Why?
|
| Rectovaginal Fistula | 1 | 2016 | 7 | 0.030 |
Why?
|
| Ovulation Induction | 1 | 2016 | 60 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2017 | 6028 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 195 | 0.030 |
Why?
|
| Fertility Preservation | 1 | 2016 | 61 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2020 | 1541 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2016 | 467 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2014 | 127 | 0.030 |
Why?
|
| Reproductive Health Services | 1 | 2012 | 17 | 0.030 |
Why?
|
| Adolescent Health Services | 1 | 2012 | 38 | 0.030 |
Why?
|
| Adnexa Uteri | 1 | 2012 | 9 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2016 | 547 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2016 | 587 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2012 | 235 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2012 | 139 | 0.020 |
Why?
|
| Health Surveys | 1 | 2012 | 241 | 0.020 |
Why?
|
| Platelet Function Tests | 1 | 2010 | 38 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 586 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 670 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 12116 | 0.020 |
Why?
|
| Infant | 2 | 2017 | 12339 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1259 | 0.020 |
Why?
|
| Mutation | 1 | 2022 | 5773 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 1387 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 10010 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3380 | 0.010 |
Why?
|
| Male | 1 | 2016 | 60040 | 0.010 |
Why?
|